BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2024 12:23:34 PM | Browse: 72 | Download: 235
 |
Received |
|
2024-06-27 04:01 |
|
Peer-Review Started |
|
2024-06-27 04:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-02 00:06 |
|
Revised |
|
2024-08-03 03:50 |
|
Second Decision |
|
2024-08-13 03:01 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-08-13 09:25 |
|
Articles in Press |
|
2024-08-13 09:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-08-22 21:09 |
|
Typeset the Manuscript |
|
2024-08-28 06:06 |
|
Publish the Manuscript Online |
|
2024-11-12 12:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Gene targets with therapeutic potential in hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Syifaus Shodry, Yuliono Trika Nur Hasan, Iwal Reza Ahdi and Zulvikar Syambani Ulhaq |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zulvikar Syambani Ulhaq, MD, PhD, Research Scientist, Research Center for Preclinical and Clinical Medicine, National Research and Innovation Agency Republic of Indonesia, Cibinong Science Center, Jl. Raya Jakarta-Bogor, Cibinong 16911, Indonesia. zulhaq@kedokteran.uin-malang.ac.id |
| Key Words |
Hepatocellular carcinoma; EZH2; Target genes; Biomarkers; Potential therapeutic |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths due to late diagnosis and high recurrence rates. Key biomarkers like EZH2 and FABP5, along with other genetic biomarkers provide insights into HCC progression and potential therapeutic targets. |
| Publish Date |
2024-11-12 12:23 |
| Citation |
<p>Shodry S, Hasan YTN, Ahdi IR, Ulhaq ZS. Gene targets with therapeutic potential in hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2024; 16(12): 4543-4547</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i12/4543.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i12.4543 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
